Showing results (271-280 of 283) with videos related to
Sort By:
Pageof 29
The Journal of Clinical Endocrinology and Metabolism|February 12, 2009
Guidelines for acromegaly management: an updateS Melmed, A Colao, A Barkan, et al.The Journal of Clinical Endocrinology and Metabolism|November 1, 1985
Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal menW S Evans, M L Vance, D L Kaiser, et al.Lancet (London, England)|January 1, 1983
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in manM O Thorner, J Rivier, J Spiess, et al.The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adultsD M Cook, B M K Biller, M L Vance, et al.European Journal of Endocrinology|December 3, 2005
Consensus statement: medical management of acromegalyS Melmed, F Casanueva, F Cavagnini, et al.Lancet (London, England)|July 16, 1983
Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiencyJ L Borges, R M Blizzard, M C Gelato, et al.The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Octreotide as primary therapy for acromegalyC B Newman, S Melmed, A George, et al.Journal of Endocrinological Investigation|April 2, 2004
Diagnosis and treatment of acromegaly complicationsA Giustina, F F Casanueva, F Cavagnini, et al.The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Diagnosis and complications of Cushing's syndrome: a consensus statementG Arnaldi, A Angeli, A B Atkinson, et al.Endocrine-Related Cancer|March 8, 2017
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposalS L Asa, O Casar-Borota, P Chanson, et al.Pageof 29